AngioDynamics company info

What does AngioDynamics do?
AngioDynamics (NASDAQ:ANGO) focuses on developing innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease, and oncology. AngioDynamics is committed to improving patient outcomes by providing healthcare professionals with state-of-the-art products that support a wide range of medical procedures. Their portfolio includes a broad range of devices, including catheters, port systems, and microwave ablation systems, designed to make procedures more efficient and reduce recovery times. By continuously investing in research and development, AngioDynamics aims to advance its technologies and expand its product offerings to meet the evolving needs of the healthcare industry. Their objective is not only to lead in the markets they serve but also to provide solutions that deliver superior clinical results and economic value to healthcare providers and patients alike.
AngioDynamics company media
Company Snapshot

Is AngioDynamics a public or private company?

key
Ownership
Public

How many people does AngioDynamics employ?

people
Employees
815

What sector is AngioDynamics in?

pie chart
Sector
Health Care

Where is the head office for AngioDynamics?

location pin
Head Office
Latham, United States

What year was AngioDynamics founded?

founded flag
Year Founded
1988
What does AngioDynamics specialise in?
/Medical Devices /Vascular Interventions /Oncology Therapies /Ablation Technology /Fluid Management /Continual Innovation

What are the products and/or services of AngioDynamics?

Overview of AngioDynamics offerings
Oncology: Offers innovative, minimally invasive medical devices for cancer diagnosis and treatment, including the NanoKnife System for the surgical ablation of soft tissues.
Vascular Interventions and Therapies: Provides a wide range of products, including thrombectomy systems, angiographic catheters, and port access needles, designed to improve patient outcomes in vascular interventions.
Vascular Access: Focuses on developing technologies that facilitate the safe, efficient delivery of intravenous therapies, including PICC (Peripherally Inserted Central Catheters) and midline catheters.
Venous Insufficiency: Offers solutions for the treatment of varicose veins and chronic venous insufficiency, such as the VenaCure EVLT system, a minimally invasive laser therapy.
Fluid Management: Develops products for the efficient management and monitoring of fluid levels within the body during medical procedures, enhancing patient care.
AngioVac System: A unique venous drainage system designed for the removal of unwanted intravascular material, offering a minimally invasive option for patients requiring venous intervention.

Who is in the executive team of AngioDynamics?

AngioDynamics leadership team
  • Mr. James C. Clemmer
    Mr. James C. Clemmer
    CEO, President & Director
  • Mr. Stephen A. Trowbridge
    Mr. Stephen A. Trowbridge
    Executive VP & CFO
  • Mr. Chad T. Campbell
    Mr. Chad T. Campbell
    Senior VP and GM of Global Vascular Access & Oncology Global Business Unit
  • Ms. Laura  Piccinini
    Ms. Laura Piccinini
    Senior VP & GM of International
  • Mr. Saleem M. Cheeks
    Mr. Saleem M. Cheeks
    Vice President of Communications
  • Mr. Benjamin H. Davis
    Mr. Benjamin H. Davis
    Senior Vice President of Business Development
  • Ms. Marna I. Bronfen-Moore
    Ms. Marna I. Bronfen-Moore
    Senior Vice President of Human Resources
  • Mr. Warren G. Nighan
    Mr. Warren G. Nighan
    Senior Vice President of Quality & Regulatory Affairs